Sonder Capital Closes Second Fund Futures II to Transform Patient Care
Bruker Appoints Laura Francis to its Board of Directors
J&J beats quarterly sales and profit estimates on cancer drug sales By Reuters
J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal By Reuters
Healthcare executives expect more IPOs and corporate dealmaking in 2025 By Reuters
Deborah Kilpatrick Joins Sonder Capital as its Newest Venture Partner
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。
